drugset
Drugs / PHiD-CV
last change Jul 2016 re-read 3 minutes ago

PHiD-CV

also known as 10-valent pneumococcal nontypeable H. influenzae protein D conjugate vaccine

Vaccine

Developed for
streptococcal infection
Investigated by
GlaxoSmithKline

Trials 1

today NCT00334334 · Ph 3
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00334334 Jun 2006 → Jul 2007 streptococcal infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as PHiD-CV “a pneumococcal conjugate vaccine (10-valent pneumococcal nontypeable H. influenzae protein D conjugate vaccine [PHiD-CV] or 7-valent cross-reacting material 197 [CRM197]...” PMID 27145999 ↗ Jul 2016
Known as 10-valent pneumococcal nontypeable H. influenzae protein D conjugate vaccine “a pneumococcal conjugate vaccine (10-valent pneumococcal nontypeable H. influenzae protein D conjugate vaccine [PHiD-CV] or 7-valent cross-reacting material 197 [CRM197]...” PMID 27145999 ↗ Jul 2016
Modality Vaccine “Pneumococcal (vaccine)” NCT00334334 ↗